Literature DB >> 7493585

Perinatal thermogenesis.

T R Gunn1, P D Gluckman.   

Abstract

The rapid initiation of thermogenesis is crucial for the survival of newborn infants. At birth the fetus must adapt to cooling, increased oxygenation and separation from the placenta. An experimental approach in the chronically instrumental fetal sheep of 'simulated birth in utero' allowed the evaluation of each of these stimuli sequentially. Cooling stimulated shivering, cardiovascular and endocrine responses but not nonshivering thermogenesis (NST). Ventilation of the cooled fetus with oxygen caused only modest NST which was not altered by an infusion of triiodothyronine. Occluding the umbilical cord was followed by a rapid substantial rise in NST which was maintained until the placental circulation was re-established. Thus the placenta is secreting factors into the fetal circulation which inhibit the ability of the brown adipose tissue to respond to either hormonal or neural stimuli. Placental prostaglandin E2 and probably adenosine are tonic inhibitors of thermogenesis in utero. Effective thermogenesis after birth requires the combination of separation from the placental inhibitors of lipolysis, increased oxygenation from breathing and the stimulation of cutaneous cold receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7493585     DOI: 10.1016/0378-3782(95)01647-l

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  3 in total

Review 1.  Practical approaches to sedation and analgesia in the newborn.

Authors:  Christopher McPherson; Cynthia M Ortinau; Zachary Vesoulis
Journal:  J Perinatol       Date:  2020-11-29       Impact factor: 2.521

Review 2.  Brown adipose tissue growth and development.

Authors:  Michael E Symonds
Journal:  Scientifica (Cairo)       Date:  2013-03-31

3.  Alteration in the time and/or mode of delivery differentially modulates early development in mice.

Authors:  Morgane Chiesa; Diana C Ferrari; Yehezkel Ben-Ari
Journal:  Mol Brain       Date:  2020-03-09       Impact factor: 4.041

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.